Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,260.00    -3.20 (-0.25%)
Bid:
1,261.40
Ask:
1,261.80
Spread: 0.40 (0.032%)
Market Cap: £104.53b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Director/PDMR Shareholding

31 Mar 2026 11:00

RNS Number : 7037Y
Rolls-Royce Holdings plc
31 March 2026
 

31 March 2026

Rolls-Royce Holdings plc

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Rolls-Royce Holdings plc (the Company) announces that the following person(s) discharging managerial responsibilities transacted in ordinary shares of 20p each in the Company (Shares) under the Rolls-Royce Incentive Plan, as set out in the remuneration policy approved by shareholders at the 2025 AGM.

Vesting of awards

The following Shares vested on 30 March 2026 in relation to awards made on 28 March 2024 following a percentage of base salary being deferred into Shares for two years under the Rolls-Royce Incentive Plan.

PDMR

Shares vested

Shares sold to cover statutory withholding liabilities

Shares retained

Tufan Erginbilgic

7,834

3,690

 

4,144

 

Helen McCabe

3,028

1,427

1,601

 

 

The salary deferred Shares above includes accumulated dividends during the vesting periods which were reinvested in Shares on 30 March 2026 based on the average mid-market closing price on the three days leading up to and including the relevant dividend record dates.

PDMR

Share price

Number of shares

Tufan Erginbilgic

£7.182

64

£10.7883

32

Helen McCabe

£7.182

24

£10.7883

12

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Tufan Erginbilgic

2

Reason for the notification

 

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rolls-Royce Holdings plc

b)

LEI

213800EC7997ZBLZJH69

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 20p each

 

GB00B63H8491

Transaction 1

b)

 

Nature of the transaction

Vest of Shares received in lieu of a percentage of base salary, including accumulated dividends reinvested in Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

Nil

7,738

£7.182

64

£10.7883

32

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

7,834

 

£804.87

 

e)

Date of the transaction

30 March 2026

f)

Place of the transaction

Outside a trading venue

Transaction 2

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£11.0852

 

3,690

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

3,690

 

£40,904.39

 

e)

Date of the transaction

30 March 2026

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Helen McCabe

2

Reason for the notification

 

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Rolls-Royce Holdings plc

b)

LEI

213800EC7997ZBLZJH69

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary Shares of 20p each

 

GB00B63H8491

Transaction 1

b)

 

Nature of the transaction

Vest of Shares received in lieu of a percentage of base salary, including accumulated dividends reinvested in Shares

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

Nil

2,992

£7.182

24

£10.7883

12

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

3,028

 

£301.83

 

e)

Date of the transaction

30 March 2026

f)

Place of the transaction

Outside a trading venue

Transaction 2

b)

Nature of the transaction

Sale of Shares to cover statutory withholding liabilities

c)

 

Price(s) and volume(s)

 

 

 

 

 

Price(s)

 

Volume(s)

£11.0852

 

1,427

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

1,427

 

£15,818.58

 

e)

Date of the transaction

30 March 2026

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

Name of officer of issuer responsible for making notification: Matthew Conacher

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLGDXSUXDGLG
Date   Source Headline
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
1st Jun 20263:00 pmRNSTotal Voting Rights
29th May 20263:30 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
8th May 20263:00 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:30 pmRNSDirector/PDMR Shareholding
1st May 202610:30 amRNSTotal Voting Rights
30th Apr 20263:00 pmRNSResult of AGM
30th Apr 20267:00 amRNSAGM Statement and Trading Update
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20262:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20264:30 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:00 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202611:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:00 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:30 pmRNSDirector/PDMR Shareholding
10th Mar 20264:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 202611:00 amRNSAnnual Report 2025 and Annual General Meeting 2026
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 202612:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20264:30 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.